Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
Virgolini I, Angelberger P, Li S, Yang Q, Kurtaran A, Raderer M, Neuhold N, Kaserer K, Leimer M, Peck-Radosavljevic M, Scheithauer W, Niederle B, Eichler HG, Valent P. Virgolini I, et al. Among authors: kurtaran a. Eur J Nucl Med. 1996 Oct;23(10):1388-99. doi: 10.1007/BF01367597. Eur J Nucl Med. 1996. PMID: 8781146
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.
Raderer M, Kurtaran A, Leimer M, Angelberger P, Niederle B, Vierhapper H, Vorbeck F, Hejna MH, Scheithauer W, Pidlich J, Virgolini I. Raderer M, et al. Among authors: kurtaran a. J Clin Oncol. 2000 Mar;18(6):1331-6. doi: 10.1200/JCO.2000.18.6.1331. J Clin Oncol. 2000. PMID: 10715305 Clinical Trial.
Case 2: myocardial metastases from a carcinoid tumor.
Penz M, Kurtaran A, Vorbeck F, Oberhuber G, Raderer M. Penz M, et al. Among authors: kurtaran a. J Clin Oncol. 2000 Apr;18(7):1596-7. doi: 10.1200/JCO.2000.18.7.1596. J Clin Oncol. 2000. PMID: 10735908 No abstract available.
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Virgolini I, Patri P, Novotny C, Traub T, Leimer M, Füger B, Li SR, Angelberger P, Raderer M, Wogritsch S, Kurtaran A, Kletter K, Dudczak R. Virgolini I, et al. Among authors: kurtaran a. Ann Oncol. 2001;12 Suppl 2:S41-5. doi: 10.1093/annonc/12.suppl_2.s41. Ann Oncol. 2001. PMID: 11762351 Free article.
Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
Fiebiger WC, Scheithauer W, Traub T, Kurtaran A, Gedlicka C, Kornek GV, Virgolini I, Raderer M. Fiebiger WC, et al. Among authors: kurtaran a. Scand J Gastroenterol. 2002 Feb;37(2):222-5. doi: 10.1080/003655202753416911. Scand J Gastroenterol. 2002. PMID: 11843061 Clinical Trial.
100 results